What is the greatest regulatory challenge in the translation of biomaterials to the clinic?

Written By Guest User

Publication Type:

Journal Article

Authors:

Prestwich, Glenn D; Sangeeta N Bhatia; Breuer, Christopher K; Dahl, Shannon L M; Mason, Chris; McFarland, Richard; McQuillan, David J; Sackner-Bernstein, Jonathan; Schox, Jeffrey; Tente, William E; Trounson, Alan

Source:

Sci Transl Med, Volume 4, Issue 160, p.160cm14 (2012)

Abstract:

Leaders in the field comment on what they perceive to be the greatest barriers to biomaterial translation.

Manuscript (PDF)

Guest User
Previous

Modeling hepatitis C virus infection using human induced pluripotent stem cells
Next

Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells